170

Hepatobiliary&Pancreas Surgery
Focuses on the health of liver, bile, and pancreatic organs.
Sub Categories on Hepatobiliary&Pancreas Surgery
{{items.name}}
Latest Articles
A drug that lowers blood lipids could treat the world's most common liver disease

A drug that lowers blood lipids could treat the world's most common liver disease

byUniversity of BarcelonaCredit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.117067The University of Barcelona has led a study that suggests using the drug kno
Updated on: July 11,2024
A drug that lowers blood lipids could treat the world's most common liver disease

A drug that lowers blood lipids could treat the world's most common liver disease

byUniversity of BarcelonaCredit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.117067The University of Barcelona has led a study that suggests using the drug kno
Updated on:July 11,2024
Gut microbiota harnessed as tool to diagnose diseases, promising results for fatty liver diagnosis

Gut microbiota harnessed as tool to diagnose diseases, promising results for fatty liver diagnosis

by University of JyväskyläThe diversity of the gut microbiota in the low (n = 25) and high (n = 37) liver fat groups. (A) Shannon index, a measure of alpha-diversity indicating species diversity.
Updated on: May 29,2024
Gut microbiota harnessed as tool to diagnose diseases, promising results for fatty liver diagnosis

Gut microbiota harnessed as tool to diagnose diseases, promising results for fatty liver diagnosis

by University of JyväskyläThe diversity of the gut microbiota in the low (n = 25) and high (n = 37) liver fat groups. (A) Shannon index, a measure of alpha-diversity indicating species diversity.
Updated on:May 29,2024
Study shows seladelpar beneficial for patients with primary biliary cholangitis

Study shows seladelpar beneficial for patients with primary biliary cholangitis

by Elana GotkineFor patients with primary biliary cholangitis, more receiving the peroxisome proliferator-activated receptor delta (PPARδ) agonist seladelpar have a biochemical response and alkaline p
Updated on: June 04,2024
Study shows seladelpar beneficial for patients with primary biliary cholangitis

Study shows seladelpar beneficial for patients with primary biliary cholangitis

by Elana GotkineFor patients with primary biliary cholangitis, more receiving the peroxisome proliferator-activated receptor delta (PPARδ) agonist seladelpar have a biochemical response and alkaline p
Updated on:June 04,2024
Involvement of the liver–gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A

Involvement of the liver–gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A

by Niigata UniversityInvolvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A. Credit: Niigata UniversityIn theirDisease Models &
Updated on: June 20,2024
Involvement of the liver–gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A

Involvement of the liver–gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A

by Niigata UniversityInvolvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A. Credit: Niigata UniversityIn theirDisease Models &
Updated on:June 20,2024
Phytic acid-based nanomedicine shows promise for metabolic dysfunction-associated steatohepatitis therapy

Phytic acid-based nanomedicine shows promise for metabolic dysfunction-associated steatohepatitis therapy

by Higher Education PressCePA exerts a liver-targeted mTOR repressive function, alleviating MASH progression and fat accumulation in high-fat diet-fed mice. Credit: Fenghua Xu, Shoujie Zhao, Yejing Zh
Updated on: July 17,2024
Phytic acid-based nanomedicine shows promise for metabolic dysfunction-associated steatohepatitis therapy

Phytic acid-based nanomedicine shows promise for metabolic dysfunction-associated steatohepatitis therapy

by Higher Education PressCePA exerts a liver-targeted mTOR repressive function, alleviating MASH progression and fat accumulation in high-fat diet-fed mice. Credit: Fenghua Xu, Shoujie Zhao, Yejing Zh
Updated on:July 17,2024
Bacteria in the bile duct may provide a new clue for treating liver disease

Bacteria in the bile duct may provide a new clue for treating liver disease

by ElsevierRepresentative flow plots showing CD69+ granzyme B+(GrB+) activated mucosal-associated invariant T (MAIT) cells within peripheral blood mononuclear cells (PBMCs) after incubation with
Updated on: June 28,2024
Bacteria in the bile duct may provide a new clue for treating liver disease

Bacteria in the bile duct may provide a new clue for treating liver disease

by ElsevierRepresentative flow plots showing CD69+ granzyme B+(GrB+) activated mucosal-associated invariant T (MAIT) cells within peripheral blood mononuclear cells (PBMCs) after incubation with
Updated on:June 28,2024
Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome

Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome

by Impact Journals LLCDS mice show a marked increase in fibrotic markers. Credit:Aging(2024). DOI: 10.18632/aging.205970A new research paper titled "Aging exacerbates oxidative stress
Updated on: July 11,2024
Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome

Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome

by Impact Journals LLCDS mice show a marked increase in fibrotic markers. Credit:Aging(2024). DOI: 10.18632/aging.205970A new research paper titled "Aging exacerbates oxidative stress
Updated on:July 11,2024
Microproteins exclusively produced in liver tumors could lead to cancer vaccines

Microproteins exclusively produced in liver tumors could lead to cancer vaccines

by IMIM (Hospital del Mar Medical Research Institute)Credit: Pixabay/CC0 Public DomainA study led by the Hospital del Mar Research Institute, with Cima University of Navarra and Pompeu Fabra Universit
Updated on: July 11,2024
Microproteins exclusively produced in liver tumors could lead to cancer vaccines

Microproteins exclusively produced in liver tumors could lead to cancer vaccines

by IMIM (Hospital del Mar Medical Research Institute)Credit: Pixabay/CC0 Public DomainA study led by the Hospital del Mar Research Institute, with Cima University of Navarra and Pompeu Fabra Universit
Updated on:July 11,2024
An artificial hepatocyte growth factor mimetic ameliorates non-alcoholic steatohepatitis in mouse model

An artificial hepatocyte growth factor mimetic ameliorates non-alcoholic steatohepatitis in mouse model

byKanazawa UniversityCredit:iScience(2024). DOI: 10.1016/j.isci.2024.110426A research group led by Associate Professor Katsuya Sakai, Researcher Nichole Marcela Rojas-Chaverra, and P
Updated on: August 26,2024
An artificial hepatocyte growth factor mimetic ameliorates non-alcoholic steatohepatitis in mouse model

An artificial hepatocyte growth factor mimetic ameliorates non-alcoholic steatohepatitis in mouse model

byKanazawa UniversityCredit:iScience(2024). DOI: 10.1016/j.isci.2024.110426A research group led by Associate Professor Katsuya Sakai, Researcher Nichole Marcela Rojas-Chaverra, and P
Updated on:August 26,2024
Scientists call on countries to 'declare health emergency' to end hepatitis in Asia

Scientists call on countries to 'declare health emergency' to end hepatitis in Asia

by Joel Adriano, SciDev.NetA microscopic image of the Hepatitis B virus, taken by the Centers for Disease Control and PreventionCountries in Asia Pacific are unlikely to meet their commitment to elimi
Updated on: July 08,2024
Scientists call on countries to 'declare health emergency' to end hepatitis in Asia

Scientists call on countries to 'declare health emergency' to end hepatitis in Asia

by Joel Adriano, SciDev.NetA microscopic image of the Hepatitis B virus, taken by the Centers for Disease Control and PreventionCountries in Asia Pacific are unlikely to meet their commitment to elimi
Updated on:July 08,2024
Liver cancer 'signature' in gut holds clues to cancer risk

Liver cancer 'signature' in gut holds clues to cancer risk

by Caroline Tang,University of New South WalesCredit: Thirdman from PexelsPeople with non-alcohol-related liver cancer have a unique gut microbiome profile which could help predict disease risk,
Updated on: June 20,2024
Liver cancer 'signature' in gut holds clues to cancer risk

Liver cancer 'signature' in gut holds clues to cancer risk

by Caroline Tang,University of New South WalesCredit: Thirdman from PexelsPeople with non-alcohol-related liver cancer have a unique gut microbiome profile which could help predict disease risk,
Updated on:June 20,2024
More News
Categories
Allergy&Clinical immunology
Anesthesiology & Pain
Cardiovascular Diseases
Dermatology
Diabetes & Endocrinology
Emergency Medicine & Critical Care
ENT & HN
Family Medicine
Gastroenterology
General Surgery
Geriatrics
Hematology&Oncology
Infectious Diseases
Nephrology & Urology
Neurology
Nutrition
OB & GYN
Ophthalmology
Orthopedics & Sports medicine
Pediatrics
Plastic Surgery
Psychiatry & Mental Health
Public Health & Prevention
Pulmonology
Rheumatology
Stomatology
Sleep
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com